Artificial Intelligence in ALK -Rearranged NSCLC: Forecasting Response and Resistance.

Simple Summary: ALK-positive non-small-cell lung cancer is a distinct molecular subtype for which targeted therapies have significantly enhanced patient outcomes. However, prediction of treatment response and understanding of resistance mechanisms remain clinically challenging. Artificial intelligen...

Descripción completa

Detalles Bibliográficos

Publicado en:	Cancers Vol. 18; no. 6; pp. 973 - 989
Autores principales:	Koulouris, Andreas, Tsagkaris, Christos, Kalaitzidis, Konstantinos, Tsakonas, Georgios, Mountzios, Giannis
Formato:	research systematic review tables/charts Journal Article
Publicado:	MDPI Mar2026
Acceso en línea:	Ver este registro en EBSCOhost